The epidemiology of nonsteroidal anti-inflammatory drugs

被引:55
|
作者
Tenenbaum, J [1 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Dept Med, Baycrest Geriatr Ctr,Toronto Hosp, Toronto, ON M5G 1X5, Canada
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY | 1999年 / 13卷 / 02期
关键词
cyclo-oxygenase-2 specific inhibitors; gastrointestinal toxicity; misoprostol; nonsteroidal anti-inflammatory drugs; omeprazole;
D O I
10.1155/1999/361651
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonsteroidal anti-inflammatory drug (NSAID) use has increased dramatically in the past two decades. A large proportion of the elderly population (more than 65 years of age) holds a current or recent NSAID prescription, accounting for approximately 90% of all NSAID prescriptions. Despite studies that advise finding alternatives for NSAIDs for the management of osteoarthritis, physicians often prescribe NSAIDs first for such common musculoskeletal conditions. Despite being identified as risk factors for gastrointestinal complications, the simultaneous use of two NSAIDs and the coadministration of NSAIDs with corticosteroids and with coumadin continue to occur. The point prevalence of NSAID-induced ulcers is 10% to 30%, and 15% to 35% of all peptic ulcer complications are caused by NSAIDs. The increased risk of gastrointestinal complications when NSAIDs are used is 3% to 5%. This risk increases with other identified risk factors leg, older age, previous gastrointestinal history, comorbid diseases and poor health). Gastrointestinal causes of hospitalization leg, gastrointestinal hemorrhage and perforation) and death have increased in parallel to increased NSAID use. 'Antiulcer' agents are prescribed twice as often in NSAID users, and the economic impact leg, diagnostic tests and hospitalization) is that about one-third of the arthritis budget has been dedicated to deal with gastrointestinal side effects of NSAIDs. Misoprostol and omeprazole have been shown to be cytoprotective for the gastroduodenal mucosa when NSAIDs are used, and misoprostol has been shown to reduce the risk of gastroduodenal ulcer complications. Eco nomic evaluations have suggested that these agents are a cost effective means of dealing with such NSAID-associated problems. Although no NSAID is totally safe, a number of studies have demonstrated that NSAIDs may be ranked according to relative gastrointestinal toxicity. The role of Helicobacter pylori in NSAID associated problems remains uncertain.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 50 条
  • [31] The effect of nonsteroidal anti-inflammatory drugs on tissue healing
    Chen, Michael R.
    Dragoo, Jason L.
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2013, 21 (03) : 540 - 549
  • [32] Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
    Umar, Asad
    Steele, Vernon E.
    Menter, David G.
    Hawk, Ernest T.
    SEMINARS IN ONCOLOGY, 2016, 43 (01) : 65 - 77
  • [33] Safety of rofecoxib in nonsteroidal anti-inflammatory drugs intolerance
    Muñoz-Bellido, FJ
    Terrón, M
    León, A
    ALLERGY, 2003, 58 (10) : 1072 - 1075
  • [34] Nonsteroidal anti-inflammatory drugs and risk of lung cancer
    Hernandez-Diaz, Sonia
    Garcia Rodriguez, Luis A.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) : 1565 - 1572
  • [35] The Effects of Nonsteroidal Anti-Inflammatory Drugs on Blood Pressure in Hypertensive Patients
    Snowden, Stanley
    Nelson, Robert
    CARDIOLOGY IN REVIEW, 2011, 19 (04) : 184 - 191
  • [36] Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
    Kim, Seung-Hyun
    Sanak, Marek
    Park, Hae-Sim
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (02) : 177 - +
  • [37] Effects of Nonsteroidal Anti-inflammatory Drugs on Osseointegration: A Review
    Fernandes Gomes, Francisco Isaac
    Brito Aragao, Maria Gerusa
    Teixeira Pinto, Vicente de Paulo
    Gondim, Delane Viana
    Barroso, Francisco Cesar
    Rodrigues e Silva, Antonio Alfredo
    Bezerra, Mirna Marques
    Chaves, Helliada Vasconcelos
    JOURNAL OF ORAL IMPLANTOLOGY, 2015, 41 (02) : 219 - 230
  • [38] Nonsteroidal anti-inflammatory drugs and their risk: a story still in development INTRODUCTION
    Simon, Lee S.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [39] The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature
    Hawkins, C
    Hanks, GW
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (02) : 140 - 151
  • [40] Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level
    Gunaydin, Caner
    Bilge, S. Sirri
    EURASIAN JOURNAL OF MEDICINE, 2018, 50 (02) : 116 - 121